Haleon plc (HLN) Research
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Market snapshot
- Symbol
- HLN
- Price
- $8.96
- Day change
- +1.01%
- Market cap
- $29.5B
- P/E ratio
- 29.17x
- 52-week range
- 8.65-11.28
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Next earnings
- in 1 month
- Analyst price target
- $10.20
Recent news
- Haleon performance might be stronger than you think, analyst repeats 'buy' rating
Jefferies still sees upside in Haleon PLC (LSE:HLN, NYSE:HLN), even after cutting its price target, arguing the consumer healthcare group’s headline growth...
- Haleon hit by weak cold season but strong toothpaste sales keep outlook on track
Haleon PLC (LSE:HLN, NYSE:HLN) reported modest sales growth in the first quarter as strength in oral health was offset by a weak cold and flu season. The...
- Ecora Royalties reveals "solid start" to year
Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR), in its first-quarter trading update, told investors that its portfolio contribution more...
Peer companies
Open Haleon plc (HLN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.